AVAILABILITY OF CANCER DRUGS IN POLAND IN COMPARISON WITH OTHER EUROPEAN COUNTRIES (Dostepnosc leków onkologicznych w Polsce na tle krajów europejskich(

• Authors: Nojszewska Ewelina
• Languages of publication: PL

Abstracts

EN

This paper presents different aspects of burden of cancer to individual, society and economy in terms of incidence, mortality as well as direct and indirect costs associated with cancer. European and Polish cancer incidence is increasing and mortality decreasing indicating the impact of screening programs and improvements in treatment. Spending on cancer is increasing but too low and still not in parity with the relative burden of cancer compared to other diseases. Accessibility to cancer drugs (especially innovative drugs) is not sufficient in Poland and in comparison to European countries. The public spending on cancer drugs is increasing but at too low rate.

Keywords

EN

CANCER DRUGS AVAILABILITY (POLAND)

Discipline

• ECONOMICS: ECONOMICS

• Publisher: Oficyna Wydawnicza Uczelni Łazarskiego
• Journal: Myśl Ekonomiczna i Prawna
• Year: 2009
• Issue: 1(24)
• Pages: 53-65
• Document type: ARTICLE

Contributors

author

Nojszewska Ewelina

• Ewelina Nojszewska, Szkola Glówna Handlowa w Warszawie, Kolegium Gospodarki Swiatowej, Katedra Ekonomii II, al. Niepodleglosci 162, 02-554 Warszawa, Poland

Identifiers

CEJSH db identifier

10PLAAAA08214